Aspirin may reduce prostate cancer risk
A US study has found that a daily dose of aspirin may reduce the risk of prostate cancer, but Cancer Research UK has noted that regular use of aspirin can cause serious side-effects and should not be undertaken unless recommended by a doctor.
Several previous studies have looked at the possibility of an association between aspirin use and a reduced risk of prostate cancer.
In the latest study, scientists at the Fred Hutchinson Cancer Research Centre in Seattle, led by Dr Janet Stanford, looked at data on 1,001 prostate cancer patients and a similar number of cancer-free volunteers.
Read the whole article at Cancer Research UK
Reference
- Salinas, C. et al (2010). Use of Aspirin and Other Nonsteroidal Antiinflammatory Medications in Relation to Prostate Cancer Risk American Journal of Epidemiology DOI: 10.1093/aje/kwq175
Keywords: prostate cancer, aspirin, non-steroidal anti-inflammatory drugs
13. 8. 2010 Cancer Research UK
